Skip to main content
Vaginal DysbiosisFertilityIVF and assisted reproductionMicrobiomeDrugPhase 2

What this study is

The goal of this clinical trial is to evaluate FB301 during a mock frozen embryo transfer (FET) cycle in pre-menopausal women aged 18 to 45 years with a prior failed FET and a defined vaginal bacterial imbalance (dysbiosis).

The main question it aims to answer is:

  • Does treatment with FB301 during a mock FET cycle change the proportion of participants who meet the predefined vaginal bacterial threshold compared with placebo?

Researchers will compare:

  • FB301 given after an initial vaginal cleansing with chlorhexidine (an antiseptic solution),
  • FB301 given after an initial vaginal cleansing with saline (saltwater), and
  • A placebo capsule given after an initial vaginal cleansing with saline to determine whether these approaches affect vaginal bacterial composition and pregnancy outcomes.

Participants will take study treatment for 15 days during a "mock" FET cycle. In a mock cycle, participants receive the hormones needed to prepare the uterus for embryo transfer, but no embryo is transferred. After completing the mock cycle, participants may proceed with their planned frozen embryo transfer and will be followed during pregnancy until birth.

Participants will:

  • Undergo a vaginal cleansing before receiving the first dose of FB301 or placebo
  • Provide vaginal swab samples at up to 5 study visits
  • Attend the study centre for up to 8 visits and participate in up to 4 follow-up phone calls
  • Subsequently complete a mock FET cycle before proceeding with their planned frozen embryo transfer cycle

Participants who become pregnant will be followed-up until birth.

What's being tested

  • FB-301

    Intervention · DRUG

    FB301 capsule

  • Placebo

    Intervention · DRUG

    FB301 Placebo capsule

  • Chlorhexidine (0.5%) Vaginal Cleanse

    Intervention · OTHER

    Vaginal cleanse with 0.5% Chlorhexidine solution prior to first IP administration

  • Sham vaginal cleanse (saline)

    Intervention · OTHER

    Vaginal cleanse with saline solution prior to first IP administration.

Study details

Official title
A Randomized, Double-blind, Three Arm, Multi-center Phase 2 Study to Investigate the Molecular Efficacy and Safety of FB301/Chlorhexidine Compared With FB301/Sham and Placebo/Sham in a Mock FET Cycle in Female Participants 18-45 Years of Age With Asymptomatic Vaginal Molecular Dysbiosis Planning to Undergo a Frozen Embryo Transfer (FET) Cycle
Sponsor
Freya Biosciences ApS
Conditions
Vaginal Dysbiosis
Enrolling
30 people
Starts
2026-07-22
Est. completion
2027-09-30
Design
Triple-blind, randomized, parallel groups, Phase 2
Record
View on ClinicalTrials.gov ↗